NANOBIOTIX SA - ADR (NBTX) Stock Analyst Earnings Estimates
NASDAQ:NBTX - Nasdaq - US63009J1079 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 30.058M | -11.609M -138.62% | 22.281M 291.93% | 71.536M 221.06% | 74.633M 4.33% | 75.688M 1.41% | 102.73M 35.73% | 129.55M 26.11% | 280.85M 116.79% | 572.69M 103.91% | |
| EBITDA YoY % growth | -45.202M 11.40% | -25.266M 44.10% | -66.771M -164.27% | -42.976M 35.64% | 19.006M 144.22% | 14.042M -26.12% | -66.718M -575.13% | 120.61M 280.78% | 171.76M 42.41% | 74.011M -56.91% | 112.08M 51.44% | |
| EBIT YoY % growth | -46.702M 11.18% | -26.779M 42.66% | -68.392M -155.39% | -42.135M 38.39% | -82.62K 99.80% | 6.098M 7,480.78% | 10.262M 68.28% | 37.601M 266.41% | 61.708M 64.11% | 170.89M 176.93% | 457.34M 167.62% | |
| Operating Margin | N/A | -89.09% | 589.13% | -189.11% | -0.12% | 8.17% | 13.56% | 36.60% | 47.63% | 60.85% | 79.86% | |
| EPS YoY % growth | N/A -5.70% | -1.08 24.32% | -1.44 -33.33% | -0.96 33.28% | -0.55 42.68% | -0.02 96.30% | -0.60 -2,862.00% | 1.23 303.31% | 1.82 47.97% | 1.45 -20.06% | 2.13 46.67% |
All data in EUR
| Q2 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.32 31.26% | -0.17 82.31% |
| Revenue Q2Q % growth | 14.382M 54.83% | 19.992M 221.31% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.98 -250.00% | -0.55 | -0.43 | -79.59% |
| Q2 2024 Q2Q % growth | -0.46 42.50% | -0.21 | -0.25 | -119.99% |
| Q4 2023 Q2Q % growth | -0.28 | 0.10 | -0.38 | -374.51% |
| Q2 2023 Q2Q % growth | -0.80 -5.26% | -0.73 | -0.07 | -8.93% |
| Q2 2022 Q2Q % growth | -0.76 13.64% | -0.71 | -0.05 | -6.44% |
| Q4 2021 Q2Q % growth | -0.47 4.08% | -0.71 | 0.24 | 34.17% |
| Q2 2021 Q2Q % growth | -0.88 3.30% | -0.66 | -0.22 | -32.73% |
| Q4 2020 Q2Q % growth | -0.49 59.17% | -0.78 | 0.29 | 36.79% |
| Q2 2020 Q2Q % growth | -0.91 20.87% | -1.12 | 0.21 | 18.89% |
| Q4 2019 Q2Q % growth | -1.20 | -0.98 | -0.22 | -22.98% |
| Q2 2019 Q2Q % growth | -1.15 | -0.98 | -0.17 | -17.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -16.48M -150.07% | 11.874M | -28.354M | -238.79% |
| Q2 2024 Q2Q % growth | 9.289M 182.08% | 23.97M | -14.681M | -61.25% |
| Q4 2023 Q2Q % growth | 32.914M | 33.66M | -746K | -2.22% |
| Q2 2023 Q2Q % growth | 3.293M | 2.866M | 427K | 14.90% |
| Q2 2022 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q2 2021 Q2Q % growth | 10K -75.00% | 1.071M | -1.061M | -99.07% |
| Q4 2020 Q2Q % growth | 13K -58.06% | 2.04M | -2.027M | -99.36% |
| Q2 2020 Q2Q % growth | 40K 8.11% | 2.04M | -2M | -98.04% |
| Q4 2019 Q2Q % growth | 31K | 2.011M | -1.98M | -98.46% |
| Q2 2019 Q2Q % growth | 37K | 1.78M | -1.743M | -97.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |